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Abstract 
Population studies within the United States indicate increasing rates of obesity, 
considerably prominent for women within reproductive age. Maternal obesity is associated with 
the offspring’s hyperlipidemia, diabetes, and cardiovascular disease, which have chronic 
consequences. Obesity in pregnancy causes metabolic and epigenetic perturbations within the 
fetal environment, disrupting future health of offspring. This phenomenon is known as 
developmental programming​. Although the relationship between maternal undernutrition and 
developmental programming has been demonstrated, its relationship to maternal obesity remains 
understudied.  
______________________________________________________________________________ 
 
Obesity 
The obesity rates in the United States have increased from 30.5% in 1999 to 42.2% in 
2018, while severe obesity increased from 4.7% to 9.2% (​Hales et al., 2020). It is projected that 
by 2030, 50% of adults will be obese (Youfa et al., 2019), while 25% of adults will be morbidly 
obese (Ward et al., 2019). These trends can be accounted for by increased food supply, 
consumption of high calorie diets or processed foods, and large portion sizes. Additionally, 
lifestyle changes such as a decrease in physical activity and increase in sedentary activities have 
become more prominent. Cultural changes show a heavier emphasis on spending time watching 
television and electronic devices. Thus, obesity becomes a major public health issue that needs to 
be addressed.  
Obesity is a risk factor for chronic health conditions such as cardiovascular disease and 
diabetes, major causes of death in the U.S. (Youfa et al., 2020). Accumulation of adipose tissue 
around vital organs is the hallmark of obesity, which is a factor in developing chronic disease. 
One reason for this is that excess fat leads to mechanical stress and compression on organs- 
affecting their proper function. Increased pressure and resistance on arteries require the heart to 
work harder, which increases the risk for developing high blood pressure. If these symptoms 
persist long term, this causes hypertension in obese individuals. This is one of the reasons that 
secondary disease, which is often seen in the obese population, tends to develop.  
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Additionally, the accumulation of adipose tissue increases production of cell-signaling 
molecules, such as adipocytokines, that promote a pro-inflammatory state throughout the body 
(Heymsfield et al., 2017). These adipocytokines include interleukin-(IL)-6, 8, and 12, and are 
secreted by macrophages and adipocytes within adipose tissue. Pro-inflammatory factors are 
directly linked to insulin resistance and progression of Type 2 Diabetes (Castro et al., 2017). This 
is caused by the infiltration of macrophages into locations of fat accumulation, where 
adipocytokines can be released. These molecules then interfere with insulin signaling, and 
contribute to insulin resistance, which is caused by the release of free fatty acids from excess fat 
accumulation (Castro et al., 2017).  
 Pro-inflammatory factors are further promoted by another adipokine, Leptin, which 
recruits more macrophages for the secretion of these molecules. Leptin resistance is common 
within obese individuals, and interferes with its role in hunger signaling to the brain and leads to 
excess food intake. Increased circulating leptin production is additionally associated with insulin 
resistance, infertility, and reproductive success (Mahmood et al., 2013).  
Overall, excess fat accumulation leads to increased adipokines and secretion of 
pro-inflammatory adipocytokines, directly contributing to a low grade, chronic inflammatory 
environment (Heymsfield et al., 2017). This differs from typical inflammation because there are 
no signs of acute inflammation, yet cardiovascular and metabolic disorders are still developed 
through the same mechanisms.  
The relationship between obesity and excess fat accumulation leads to the development 
of increased body fat, diabetes, and high blood pressure. The combination of these health 
conditions have chronic implications. Metabolic syndrome is more likely to develop, 
characterized by long term and potentially fatal outcomes such as congestive heart failure, stroke 
and chronic kidney disease. This is prevalent in one third of the obese population (Mahmood et 
al., 2013). Other common diseases include obstruction of air pathways, sleep apnea, 
osteoarthritis, and an increase in psychiatric disorders  (Heymsfield et al., 2017). ​In addition, up 
to 47.6% of coronavirus disease 19 (COVID-19) is associated with obesity, with a higher risk of 
developing severe symptoms and complications (​Simonnet et al., 2020). These have been shown 
to be​ independent of other illnesses, such as cardiovascular disease (​Stefan et al., 2020​). 
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Maternal Obesity 
Epidemiological studies indicate that a large proportion of women that are within 
reproductive age are obese, and these trends will only become more abundant with time. In 
2017-2018, women in the United States between the age of 20-39 were reported to have a 39.9% 
obesity rate, and were more prone to severe obesity compared to men (Hales et al., 2020). 
Additionally, projections show that by 2030, the increase in obesity nationwide will mostly 
affect women, black non-Hispanic, and low income adults. Severe obesity will be the most 
common BMI category for each of these groups within the next ten years (Ward et al., 2020).  
Obesity is shown to be a leading factor in developing chronic disease, and is proven to 
have long term health consequences. Considering this, it is important to understand how obesity 
impacts reproductive processes. This includes both maternal and fetal complications.  
 
Maternal Risks 
Maternal health is compromised in the setting of obesity, as obese mothers are at 
increased risk of excessive weight gain during pregnancy, which further affects their health 
conditions. Pregnant obese women have a 4-9 times greater chance of developing gestational 
diabetes, hypertension and preeclampsia (Poston et al., 2016). Preeclampsia especially has severe 
long term consequences, causing damage to vital organs such as the cardiovascular system, 
kidneys and liver. There is also a greater risk of complications during labor and delivery. Higher 
BMI directly corresponds to complications with conception, induced labor, miscarriages, 
cesarean section, and risk for postpartum hemorrhages. Post labor, healing times and 
complications with open wounds are significantly increased. Lastly, there are long term risks in 
obese pregnancies, as long term weight retention poses health risks as well as complications for 
future pregnancies (Poston et at., 2016).  
 
Fetal Risks 
Regardless of successful conception, fetal and infant survivals are at risk. Offspring are 
commonly delivered large for gestational age, predisposing them to develop disease in their adult 
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life (Posten et al., 2016). These risks exhibit sexual dysmorphism, where male offspring are more 
likely to experience poor developmental outcomes (Myatt et al., 2016). The risk for mortality 
increases, with increased risk for unexplained stillbirth. In the first year of life, increased death 
rates also correlate to the BMI of the mother. Intergenerationally, the rate of heritability for BMI 
can range between 40% to 70% (Heymsfield et al., 2017).  Offspring have a higher risk for high 
adiposity, waist circumference, leptin, and higher systolic blood pressure (Mahmood et al., 
2013). Studies have indicated that gestational diabetes mellitus (GDM) puts offspring at risk for 
developing diabetes themselves. In these studies, offspring born to pre-diabetic or non-diabetic 
mothers had a much lower risk of diabetes compared to diabetic mothers. After GDM develops 
during the pregnancy, the risk for future diabetes significantly increases and correlates with the 
hyperglycemic intrauterine environment in which the fetus develops (Mahmood et al., 2013). 
Additionally, there is a significant increase in the risk of congenital anomalies for offspring of 
obese mothers including defects of the brain and spinal cord, excess cerebrospinal fluid, health 
and limb defects, and cleft palate (Poston et al., 2016). Overall, babies born to obese mothers are 
more likely to develop diabetes, heart disease, hypertension, and premature mortality later in life 
(Mahmood et al., 2013).  
In addition to physical complications, there is an increased risk for the development of 
psychiatric and learning disabilities. Both maternal obesity and gestational diabetes contribute to 
increased risk of autism spectrum disorder and learning disabilities of offspring (Li et al., 2016). 
There is a 1 to 3-fold increased risk in these cases (Edlow et al., 2016). Offspring are also 
susceptible to developing other disorders, such as cerebral palsy, anxiety, depression, 
schizophrenia, and eating disorders. Considering maternal obesity is directly linked to long term 
abnormalities for offspring, it is important to understand the long term implications of this.  
 
 ​Developmental Programming 
Studies indicate that lifestyle and genetics contribute to obesity and metabolic disease, 
and also originate from the prenatal, fetal, and postnatal environment (Taylor et al., 2007). Thus, 
these altered environments during the early stages of development are thought to be the reason 
behind the increased risk for chronic disease much later in life. The theory that links altered 
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environments and the disruption of growth, development, and adult disease is known as 
Developmental Programming. This theory was initially introduced by David Barker, who 
theorized that these risks do not stem from genetic factors, but instead from early environments 
that physically “program” offspring for disease (Olsen, 2014).  
Barker focused on the role of nutrition and its relationship to epigenetic modifications. 
Specifically, his studies looked at offspring of low-income neighborhoods, who later in life 
developed a very high risk for mortality, type 2 diabetes, cardiovascular disease, stroke, lung 
disease, and polycystic ovary syndrome (Padmanabhan et al., 2016). Initially, Barker’s 
hypothesis was linked to undernutrition and low birth weight, where insulin resistance, reduction 
in growth, and disruption in metabolic processes occurred. Barker showed that undernutrition 
causes an adaptive response to ensure fetal survival by centering energy and growth towards vital 
organs such as the heart and brain (Olsen, 2014). This is known as a “thrifty” phenotype, as this 
reduction of energy towards other organs increases their vulnerability later in life. This is 
because with age, the ability for plasticity decreases, and these phenotypes become fixed and 
compromises overall function (Padmanabhan et al., 2016). Ultimately, Barker demonstrated how 
undernutrition plays a large role in developmental programming of offspring directly in response 
to their environment.  
 
Programming Effect of Maternal Overnutrition: Activation of Disease 
Considering the support regarding how undernutrition drives developmental 
programming, these theories are also considered for overnutrition, as the prevalence of obesity 
continues to rise within our community. More recent findings are geared towards a “2-hit” 
hypothesis, explaining the exposure to multiple risk factors within different stages of life 
ultimately program a maladaptive response. These factors are considered to be “stressors,” where 
during perinatal life, a “first-hit” may be caused by genetic susceptibility and an altered fetal 
environment. During postnatal life, environmental stressors activate a “second-hit” in which 
underlying disease may be activated (Padmanabhan et al., 2016).  
There are multiple sources of “stressors” which can activate disease during perinatal and 
postnatal development. As previously discussed, obesity is associated with decreased fertility 
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and increased risk of medical intervention. The use of medical intervention in conception can be 
considered a perinatal stressor, and has been shown to cause epigenetic changes in the offspring 
(Padmanabhan et al., 2016). Additional stressors include lifestyle habits such as physical activity, 
diet, and substance abuse, with up to 16 % of pregnant women using drugs within the U.S. The 
effect of these stressors is clearly demonstrated between siblings, where weight gain between 
pregnancies causes the development of metabolic disease for the second child, while the first is 
metabolically not compromised (Padmanabhan et al., 2016). Programming through these 
stressors may be due to maternal overnutrition and stress, which increase the risk for developing 
disease (Padmanabhan et al., 2016). A second stressor includes development of offspring during 
postnatal life, where exercise, nutrition, and lifestyle choices can also induce the activation of 
underlying disease.  
Further stressors such as endocrine disrupting chemicals (EDCs), found within beauty 
and health supplies, contribute to perinatal and postnatal development. They interfere with 
metabolic and hormonal processes, and alter the secretion, synthesis, and binding of many 
molecular factors. EDCs have been shown to be transferred to offspring via lactation, and are 
linked to obesity, cardiovascular disease, type 2 diabetes, and cancer (Padmanabhan et al., 2016). 
The combination of these various perinatal and postnatal stressors are hypothesized to activate 
chronic disease in offspring. 
 
Epigenetic Programming 
The altered physical state of obesity changes the way in which other molecular and 
physiological mechanisms utilize and expedite energy, and how metabolic processes occur. 
Obesity is associated with epigenetic modifications of proteins, enzymes, and DNA. This 
includes alterations of DNA methylation, packing, and expression, which interfere with glucose 
metabolism (Padmanabhan et al., 2016). Oxidative stress is upregulated in obese individuals, 
which damages proteins and DNA due to the overexpression of catalytic enzymes. This is a 
potential source for programming of obesity and diabetes in offspring (Padmanabhan et al., 
2016).  
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Hyperlipidemia and Programming 
Current literature has demonstrated that the environment of maternal obesity chronically 
programs offspring for metabolic disease, although few have directly indicated the long term 
consequences of this. Generally, these studies have demonstrated that overnutrition during 
pregnancy and lactation period are correlated to obesity of the offspring (Tayor et al., 2007). The 
exact mechanisms in which this occurs remain understudied, although hyperlipidemia is thought 
to be a major source for this programming to occur.  
During early stages of pregnancy, increased levels of insulin lead to excess storage of 
lipids and upregulation of lipid transport proteins. Placental tissue samples of obese mothers are 
marked by increased lipid markers, where excess adipose accumulation leads to increased fatty 
acid delivery to the fetus through the placenta (​Heerwagen, Margaret J. R., et al., 2010). Perinatal 
exposure to hyperlipidemia has been demonstrated to cause irreversible adipose levels and alter 
organ development through the activation of pro-inflammatory pathways, mitochondrial 
function, stem-cell development, metabolism, and interference with transcriptional processes of 
genes relating to lipid production ​(​Heerwagen, Margaret J. R., et al., 2010).  
Postnatal feeding also contributes to offspring hyperlipidemia. Animal models have 
demonstrated that the suckling period contributes to high levels of adiposity in offspring. In these 
cases, mothers consuming a high fat diet during the suckling period is correlated to 
hyperlipidemia within offspring. Post-suckling, if offspring are fed a normal diet, signs of 
adiposity and hypertension within adulthood remain present, which signifies these characteristics 
are irreversible This phenotype can then be passed down to the second generation, indicating that 
these characteristics are somehow heritable (Taylor et al., 2007).  
Hyperlipidemia and high caloric diets target the central nervous system, where appetite 
and hunger suppression of offspring are altered through hypothalamic programming (Taylor et 
al., 2007). Maturation of the hypothalamus occurs during the gestation period and through early 
postnatal life, thus, the hypercaloric and hyperlipidemic environment is thought to alter these 
hunger related mechanisms throughout the pregnancy and suckling period by the transfer of fat 
across the placenta and breast milk (Taylor et al., 2007). Studies have indicated that overfeeding 
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of rats and  sheep in utero and postnatally is correlated to excess appetite and fat accumulation 
on a hypothalamic level (Taylor et al., 2007).  
 
Conclusions 
Maternal obesity has been clearly demonstrated to be linked to developmental 
programming of offspring. The environment of the gestational period alone is said to directly 
program for chronic disease and fetal risks. Despite this strong correlation, the actual 
mechanisms in which this programming occurs remain poorly understood. Potential sources 
include hyperlipidemia interference with cell signaling pathways and gene expression. Further 
research should be conducted in order to understand the etiology of these mechanisms, as 
maternal obesity continues to be a prevalent health issue for our community.  
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